NSE BSE
hester biosciences ltd stock

HESTER BIOSCIENCES LTD Share Price

- - (%)
- NSE: HESTERBIO

HESTER BIOSCIENCES LTD Share Price Update

As of the latest trading session, HESTER BIOSCIENCES LTD share price is currently at 2847.2, which is up by 82.69 from its previous closing. Today, the stock has fluctuated between 2772.25 and 2875.00. Over the past year, HESTER BIOSCIENCES LTD has achieved a return of 60.93 %. In the last month alone, the return has been 32.81 %. Read More...

HESTER BIOSCIENCES LTD Performance

Day Range

Low2772.25 High2875.00
2848.90

52 Week Range

Low 1292.85 High 2864.40
2848.90

HESTER BIOSCIENCES LTD Share Price

7048

524669

HESTERBIO

img img img img
No Data Available

Open Price

2792.15

Prev. Close

2764.50

Volume (Shares)

14099.00

Total traded value

401.66

Upper Circuit

3317.40

Lower Circuit

2211.60

Note: The current prices & values are delayed, Login to your account for live updates.

HESTER BIOSCIENCES LTD Fundamentals


(Standalone)

Market Cap (Cr) 2422.07
PE Ratio (TTM) 86.75
Book Value / Share 367.60
Beta 0.62
ROE 11.53%
EPS (TTM) 31.93
Dividend Yield 0.22%
Net Profit Qtr (Cr) 7.43

HESTER BIOSCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 72.87
Operating Expense 63.85
Net Profit 7.43
Net Profit Margin (%) 10.19
Earnings Per Share (EPS) 8.74
EBITDA 13.62
Effective Tax Rate (%) 27.27
Particulars DEC 2023 (Values in Cr)
Revenue 65.51
Operating Expense 57.87
Net Profit 6.48
Net Profit Margin (%) 9.89
Earnings Per Share (EPS) 7.61
EBITDA 12.55
Effective Tax Rate (%) 24.85
Particulars SEP 2023 (Values in Cr)
Revenue 66.43
Operating Expense 58.50
Net Profit 6.78
Net Profit Margin (%) 10.20
Earnings Per Share (EPS) 7.97
EBITDA 13.22
Effective Tax Rate (%) 25.98
Particulars JUN 2023 (Values in Cr)
Revenue 80.35
Operating Expense 72.47
Net Profit 6.47
Net Profit Margin (%) 8.05
Earnings Per Share (EPS) 7.61
EBITDA 12.21
Effective Tax Rate (%) 25.88
Particulars MAR 2023 (Values in Cr)
Revenue 60.70
Operating Expense 52.75
Net Profit 6.26
Net Profit Margin (%) 10.31
Earnings Per Share (EPS) 7.36
EBITDA 11.87
Effective Tax Rate (%) 29.66
Particulars MAR 2024 (Values in Cr)
Revenue 285.16
Operating Expense 252.68
Net Profit 27.16
Net Profit Margin (%) 9.52
Earnings Per Share (EPS) 31.93
EBITDA 51.59
Effective Tax Rate (%) 26.05
Particulars MAR 2023 (Values in Cr)
Revenue 254.00
Operating Expense 215.40
Net Profit 32.34
Net Profit Margin (%) 12.73
Earnings Per Share (EPS) 38.02
EBITDA 60.21
Effective Tax Rate (%) 26.36
Particulars MAR 2022 (Values in Cr)
Revenue 219.35
Operating Expense 170.75
Net Profit 39.52
Net Profit Margin (%) 18.01
Earnings Per Share (EPS) 46.45
EBITDA 65.22
Effective Tax Rate (%) 25.79
Particulars MAR 2021 (Values in Cr)
Revenue 208.48
Operating Expense 150.07
Net Profit 39.90
Net Profit Margin (%) 19.13
Earnings Per Share (EPS) 46.90
EBITDA 68.36
Effective Tax Rate (%) 27.16
Particulars MAR 2020 (Values in Cr)
Revenue 169.43
Operating Expense 131.12
Net Profit 31.22
Net Profit Margin (%) 18.42
Earnings Per Share (EPS) 36.70
EBITDA 55.64
Effective Tax Rate (%) 24.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 328.82
ROE % 10.39
ROCE % 9.01
Total Debt to Total Equity 0.93
EBITDA Margin 26.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 305.61
ROE % 16.17
ROCE % 13.29
Total Debt to Total Equity 0.69
EBITDA Margin 31.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share 268.38
ROE % 16.16
ROCE % 16.44
Total Debt to Total Equity 0.54
EBITDA Margin 32.67
Particulars MAR 2020 (Values in Cr)
Book Value / Share 236.36
ROE % 16.38
ROCE % 16.20
Total Debt to Total Equity 0.56
EBITDA Margin 33.70
Particulars MAR 2019 (Values in Cr)
Book Value / Share 208.61
ROE % 25.58
ROCE % 26.59
Total Debt to Total Equity 0.50
EBITDA Margin 42.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 343.70
ROE % 11.53
ROCE % 11.52
Total Debt to Total Equity 0.51
EBITDA Margin 23.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 315.54
ROE % 15.62
ROCE % 17.26
Total Debt to Total Equity 0.27
EBITDA Margin 29.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 279.28
ROE % 18.11
ROCE % 23.26
Total Debt to Total Equity 0.14
EBITDA Margin 32.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 238.72
ROE % 16.32
ROCE % 19.73
Total Debt to Total Equity 0.23
EBITDA Margin 32.84
Particulars MAR 2019 (Values in Cr)
Book Value / Share 210.93
ROE % 26.94
ROCE % 31.14
Total Debt to Total Equity 0.25
EBITDA Margin 41.39
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.81
Total Assets 669.96
Total Liabilities 669.96
Total Equity 288.54
Share Outstanding 8506865
Price to Book Ratio 4.42
Return on Assets (%) 3.97
Return on Capital (%) 4.78
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.20
Total Assets 562.16
Total Liabilities 562.16
Total Equity 267.39
Share Outstanding 8506865
Price to Book Ratio 8.61
Return on Assets (%) 6.99
Return on Capital (%) 8.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 21.26
Total Assets 411.04
Total Liabilities 411.04
Total Equity 235.95
Share Outstanding 8506865
Price to Book Ratio 6.86
Return on Assets (%) 8.37
Return on Capital (%) 10.11
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 23.53
Total Assets 386.60
Total Liabilities 386.60
Total Equity 206.49
Share Outstanding 8506865
Price to Book Ratio 3.88
Return on Assets (%) 7.54
Return on Capital (%) 9.25
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 42.07
Total Assets 299.45
Total Liabilities 299.45
Total Equity 181.15
Share Outstanding 8506865
Price to Book Ratio 7.33
Return on Assets (%) 13.88
Return on Capital (%) 15.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.96
Total Assets 545.81
Total Liabilities 545.81
Total Equity 292.38
Share Outstanding 8506865
Price to Book Ratio 4.42
Return on Assets (%) 5.92
Return on Capital (%) 7.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.98
Total Assets 424.44
Total Liabilities 424.44
Total Equity 268.43
Share Outstanding 8506865
Price to Book Ratio 8.61
Return on Assets (%) 9.31
Return on Capital (%) 10.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.24
Total Assets 282.01
Total Liabilities 282.01
Total Equity 237.58
Share Outstanding 8506865
Price to Book Ratio 6.86
Return on Assets (%) 14.14
Return on Capital (%) 15.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.19
Total Assets 277.19
Total Liabilities 277.19
Total Equity 203.08
Share Outstanding 8506865
Price to Book Ratio 3.88
Return on Assets (%) 11.26
Return on Capital (%) 12.89
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 240.24
Total Liabilities 240.24
Total Equity 179.43
Share Outstanding 8506865
Price to Book Ratio 7.33
Return on Assets (%) 18.25
Return on Capital (%) 20.71
Particulars MAR 2023 (Values in Cr)
Net Income 40.15
Cash from Operations 31.70
Cash from Investing -76.99
Cash from Financing 41.75
Net change in Cash -11.59
Free Cash Flow 109.46
Particulars MAR 2022 (Values in Cr)
Net Income 53.50
Cash from Operations 25.82
Cash from Investing -116.58
Cash from Financing 111.53
Net change in Cash 3.48
Free Cash Flow 121.53
Particulars MAR 2021 (Values in Cr)
Net Income 50.10
Cash from Operations 71.99
Cash from Investing -38.37
Cash from Financing -18.21
Net change in Cash -2.26
Free Cash Flow 112.73
Particulars MAR 2020 (Values in Cr)
Net Income 41.32
Cash from Operations 47.70
Cash from Investing -74.47
Cash from Financing 18.74
Net change in Cash -17.11
Free Cash Flow 121.20
Particulars MAR 2019 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income 43.92
Cash from Operations 41.42
Cash from Investing -71.96
Cash from Financing 41.37
Net change in Cash 2.77
Free Cash Flow 114.07
Particulars MAR 2022 (Values in Cr)
Net Income 53.25
Cash from Operations 32.34
Cash from Investing -110.58
Cash from Financing 94.96
Net change in Cash 0.28
Free Cash Flow 123.01
Particulars MAR 2021 (Values in Cr)
Net Income 54.78
Cash from Operations 54.59
Cash from Investing -3.72
Cash from Financing -41.32
Net change in Cash -3.94
Free Cash Flow 58.84
Particulars MAR 2020 (Values in Cr)
Net Income 41.22
Cash from Operations 37.17
Cash from Investing -21.33
Cash from Financing -1.39
Net change in Cash 3.09
Free Cash Flow 45.57
Particulars MAR 2019 (Values in Cr)
Net Income 59.75
Cash from Operations 51.77
Cash from Investing -24.69
Cash from Financing -20.29
Net change in Cash -8.79
Free Cash Flow 63.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
HESTER BIOSCIENCES LTD 2770.00 124.77 8.07 2356.40 1292.90 / 2791.00
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
HESTER BIOSCIENCES LTD 2770.00 86.75 7.53 2356.40 1292.90 / 2791.00
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2696.40
  • 26 Days 2405.90
  • 10 Days 2635.90
  • 50 Days 2188.60
  • 12 Days 2619.20
  • 100 Days 1914.60
  • 20 Days 2487.00
  • 200 Days 1681.60
2747.47
PIVOT
First Resistance 2816.03
Second Resistance 2867.57
Third Resistance 2936.13
First Support 2695.93
Second Support 2627.37
Third Support 2575.83
RSI 65.68
MACD 213.33
Commodity Channel Index (CCI) 109.89
ADX 77.09
Williams % R -7.95

Over 1 Month

down

32.81

Over 3 Months

down

74.33

Over 6 Months

down

78.68

Over 1 Year

down

60.93

Over 3 Years

down

3.18

Over 5 Years

down

9.51

HESTER BIOSCIENCES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

HESTER BIOSCIENCES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
45.74
Promoter Holdings
53.73
FII
0.52
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Rajiv Dinesh Gandhi Shareholding of Promoter and Promoter Group 890397.0 10.47
Sanjiv Dinesh Gandhi Shareholding of Promoter and Promoter Group 697820.0 8.2
Nina Rajiv Gandhi Shareholding of Promoter and Promoter Group 696340.0 8.19
Shaila Bhupendra Gandhi Shareholding of Promoter and Promoter Group 491300.0 5.78
Ravin Gandhi Shareholding of Promoter and Promoter Group 403320.0 4.74
Bela Gandhi Shareholding of Promoter and Promoter Group 400635.0 4.71
Bhupendra Vithaldas Gandhi Shareholding of Promoter and Promoter Group 399100.0 4.69
Kuntal Hasmukhlal Shah Public Shareholding 261334.0 3.07
Biolink Healthcare Limited Shareholding of Promoter and Promoter Group 248838.0 2.93
Manish Jain Public Shareholding 245412.0 2.88
Anup Chandravadan Kapadia Shareholding of Promoter and Promoter Group 228354.0 2.68
Darshna Dinesh Kapadia Public Shareholding 153600.0 1.81
Vinay Shah Public Shareholding 108900.0 1.28
Manish Prataprai Gandhi Public Shareholding 100000.0 1.18
Jagrut Prataprai Gandhi Public Shareholding 100000.0 1.18
Sandeep Shantilal Gala Public Shareholding 95588.0 1.12
Hester Coatings Llp Shareholding of Promoter and Promoter Group 64000.0 0.75
Hester Diagnostics Private Limited Shareholding of Promoter and Promoter Group 24000.0 0.28
Hetal Sanjiv Gandhi Shareholding of Promoter and Promoter Group 19590.0 0.23
Yash Rajiv Gandhi Shareholding of Promoter and Promoter Group 7250.0 0.09
Bhupendra Vithaldas Gandhi Huf Shareholding of Promoter and Promoter Group 0.0 0.0

HESTER BIOSCIENCES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-13 8.0 Final 2023-09-14 Equity shares 2022-08-11 10.0 Final 2022-08-12 Equity shares 2021-08-05 10.0 Final 2021-08-07 Equity shares 2020-08-27 6.6 Final 2020-08-29 Equity shares 2019-07-18 7.0 Final 2019-07-20 Equity shares 2018-11-09 2.0 Interim 2 2018-11-12 Equity shares 2018-08-30 2.0 Interim 1 2018-08-31 Equity shares 2018-08-02 6.0 Final 2018-08-04 Equity shares 2017-11-16 4.0 Interim 2017-11-17 Equity shares 2017-07-20 2.3 Final 2017-07-22 Equity shares 2016-11-03 3.0 Interim 2016-11-04 Equity shares 2016-07-21 1.1 Final 2016-07-23 Equity shares 2016-03-17 3.0 Interim 2016-03-18 Equity shares 2015-09-10 3.1 Final 2015-09-12 Equity shares 2014-09-18 2.0 Final 2014-09-20 Equity shares 2013-08-07 2.0 Final 2013-08-10 Equity shares 2012-08-27 1.0 Final 2012-08-28 Equity shares 2011-08-25 3.5 Final 2011-08-27 Equity shares 2010-07-22 3.0 Final 2010-07-24 Equity shares 2009-08-13 2.5 Final 2009-08-15 Equity shares 2008-08-21 2.5 Final 2008-08-23 Equity shares 2007-09-06 2.0 Final 2007-09-08 Equity shares 2005-06-06 0.0 Final 2005-06-08 Equity shares
Ex-Date Ex-Bonus Ratio
2012-09-29 2012-09-27 1:2
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About HESTER BIOSCIENCES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by HESTER BIOSCIENCES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Hester Biosciences Ltd?

Answer Field

The share price of Hester Biosciences Ltd for NSE is ₹ 2847.2 and for BSE is ₹ 2860.

What is the Market Cap of Hester Biosciences Ltd?

Answer Field

The market cap of Hester Biosciences Ltd for NSE is ₹ 2,422.07 Cr. and for BSE is ₹ 2,432.96 Cr. as of now.

What is the 52 Week High and Low of Hester Biosciences Ltd?

Answer Field

The 52 Week High and Low of Hester Biosciences Ltd for NSE is ₹ 2875.00 and ₹ 1292.85 and for BSE is ₹ 2871.85 and ₹ 1292.90.

How to Buy Hester Biosciences Ltd share?

Answer Field

You can trade in Hester Biosciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Hester Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.0%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader